FI940427L - Therapeutic systems that act through the skin - Google Patents

Therapeutic systems that act through the skin Download PDF

Info

Publication number: FI940427L
Authority: FI; Finland
Prior art keywords: skin; act; therapeutic systems; therapeutic; systems
Prior art date: 1991-07-30

Application number

FI940427A

Other languages

Finnish (fi)

Swedish (sv)

Other versions

FI940427A0 (en

Inventor

Jutta Riedl

Ralph Lipp

Matthias Hartisch

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-07-30

Filing date

1994-01-28

Publication date

1994-01-28

1994-01-28 Application filed by Schering Ag filed Critical Schering Ag

1994-01-28 Publication of FI940427A0 publication Critical patent/FI940427A0/en

1994-01-28 Publication of FI940427L publication Critical patent/FI940427L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Electrotherapy Devices (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

FI940427A 1991-07-30 1994-01-28 Therapeutic systems that act through the skin FI940427L (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE4125611		1991-07-30
DE4210165A DE4210165A1 (en)	1991-07-30	1992-03-25	TRANSDERMAL THERAPEUTIC SYSTEMS
PCT/EP1992/001515 WO1993002669A1 (en)	1991-07-30	1992-07-07	Transdermal therapeutic systems

Publications (2)

Publication Number	Publication Date
FI940427A0 FI940427A0 (en)	1994-01-28
FI940427L true FI940427L (en)	1994-01-28

Family

ID=25906037

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI940427A FI940427L (en)	1991-07-30	1994-01-28	Therapeutic systems that act through the skin

Country Status (14)

Country	Link
EP (1)	EP0596903B1 (en)
JP (1)	JPH06509346A (en)
AT (1)	ATE151985T1 (en)
AU (1)	AU676826B2 (en)
CA (1)	CA2114537A1 (en)
DE (2)	DE4210165A1 (en)
DK (1)	DK0596903T3 (en)
ES (1)	ES2103952T3 (en)
FI (1)	FI940427L (en)
GR (1)	GR3024097T3 (en)
HU (1)	HU217215B (en)
NO (1)	NO307736B1 (en)
PT (1)	PT100737B (en)
WO (1)	WO1993002669A1 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69326461T2 (en) *	1992-06-11	2000-05-04	Theratech Inc., Salt Lake City	USE OF GLYCERINE FOR DAMPING TRANSDERMAL MEDICINE ADMINISTRATION
US5843979A (en) *	1993-02-25	1998-12-01	Bristol-Myers Squibb Company	Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
US5460820B1 (en) †	1993-08-03	1999-08-03	Theratech Inc	Method for providing testosterone and optionally estrogen replacement therapy to women
DE4332094C2 (en) *	1993-09-22	1995-09-07	Lohmann Therapie Syst Lts	Active substance plaster which can be produced without solvent and process for its preparation
DE4405899A1 (en) *	1994-02-18	1995-08-24	Schering Ag	Agent for transdermal application containing desogestrel
DE4429667C2 (en) *	1994-08-20	1996-07-11	Lohmann Therapie Syst Lts	Estradiol TTS with water-binding additives and process for its preparation
ES2180658T3 (en) *	1994-11-17	2003-02-16	Toray Industries	PREPARED FOR PERCUTANEOUS ABSORPTION.
DE19526864A1 (en) *	1995-07-22	1997-01-23	Labtec Gmbh	Hormone patches
DE19533089C1 (en) *	1995-09-07	1997-05-22	Hexal Ag	Tacrine patch
DE19626621A1 (en) *	1996-07-02	1998-01-08	Hexal Ag	Plaster for transdermal application of pergolide
DE19701949A1 (en) *	1997-01-13	1998-07-16	Jenapharm Gmbh	Transdermal therapeutic system
ATE293960T1 (en) *	1997-02-28	2005-05-15	Minnesota Mining & Mfg	TRANSDERMAL DEVICE FOR ADMINISTRATION OF TESTOSTERONE
FR2761889B1 (en) *	1997-04-11	1999-12-31	Oreal	PHARMACEUTICAL, COSMETIC OR DERMO-PHARMACEUTICAL PATCH FOR THE DELIVERY OF SEVERAL ACTIVE COMPOUNDS OF DIFFERENT NATURE
US7011843B2 (en)	1997-10-01	2006-03-14	Lts Lohmann-Therapie Systeme Ag	Method for protecting a human being against health impairment by ingestion of a transdermal therapeutic system
DE10019171A1 (en) *	2000-04-07	2001-10-18	Schering Ag	Compositions for use as penetration enhancers in transdermal formulations for highly lipophilic active ingredients
DE10107663B4 (en) *	2001-02-19	2004-09-09	Lts Lohmann Therapie-Systeme Ag	Testosterone-containing transdermal therapeutic system, process for its preparation and its use
IL152486A0 (en)	2002-10-25	2003-05-29	Meir Eini	Alcohol-free cosmetic and pharmaceutical foam carrier
US7704518B2 (en)	2003-08-04	2010-04-27	Foamix, Ltd.	Foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en)	2002-10-25	2017-06-06	Foamix Pharmaceuticals Ltd.	Nonsteroidal immunomodulating kit and composition and uses thereof
NZ540166A (en)	2002-10-25	2007-06-29	Foamix Ltd	Cosmetic and pharmaceutical foam
US20080138296A1 (en)	2002-10-25	2008-06-12	Foamix Ltd.	Foam prepared from nanoemulsions and uses
US9265725B2 (en)	2002-10-25	2016-02-23	Foamix Pharmaceuticals Ltd.	Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en)	2002-10-25	2010-04-20	Foamix, Ltd.	Penetrating pharmaceutical foam
US10117812B2 (en)	2002-10-25	2018-11-06	Foamix Pharmaceuticals Ltd.	Foamable composition combining a polar solvent and a hydrophobic carrier
MXPA06002163A (en) *	2003-08-25	2006-05-22	Foamix Ltd	Penetrating pharmaceutical foam.
US20080260655A1 (en)	2006-11-14	2008-10-23	Dov Tamarkin	Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en)	2007-08-07	2014-01-28	Foamix Ltd.	Wax foamable vehicle and pharmaceutical compositions thereof
WO2009037061A2 (en)	2007-09-13	2009-03-26	Basf Se	Use of hydrophobin polypeptides as penetration enhancers
US9439857B2 (en)	2007-11-30	2016-09-13	Foamix Pharmaceuticals Ltd.	Foam containing benzoyl peroxide
WO2009072007A2 (en)	2007-12-07	2009-06-11	Foamix Ltd.	Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
DE102008006791B4 (en)	2008-01-30	2011-11-24	Lts Lohmann Therapie-Systeme Ag	Transdermal therapeutic system with urea component and method for its production
WO2010050889A1 (en) *	2008-10-31	2010-05-06	Moberg Derma Ab	Topical composition comprising a combination of at least two penetration enhancing agents
WO2010125470A2 (en)	2009-04-28	2010-11-04	Foamix Ltd.	Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en)	2009-07-29	2011-02-03	Foamix Ltd.	Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en)	2009-07-29	2011-02-03	Foamix Ltd.	Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2776471C (en)	2009-10-02	2019-02-12	Foamix Ltd.	Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US9849142B2 (en)	2009-10-02	2017-12-26	Foamix Pharmaceuticals Ltd.	Methods for accelerated return of skin integrity and for the treatment of impetigo
MX377365B (en)	2016-09-08	2025-03-10	Journey Medical Corp	COMPOSITIONS AND METHODS FOR TREATING ROSACEA AND ACNE.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5855411A (en) *	1981-09-28	1983-04-01	Nitto Electric Ind Co Ltd	Base material composition and medicinal composition for external use
EP0224981A3 (en) *	1985-11-04	1988-08-10	Paco Research Corporation	Nitroglycerin transdermal delivery system
ES2081823T3 (en) *	1988-10-27	1996-03-16	Schering Ag	AGENT FOR TRANSDERMIC APPLICATION, CONTAINING GESTODEN.
DE69010076T2 (en) *	1989-05-25	1994-12-08	Takeda Chemical Industries Ltd	Transdermal therapeutic agent.
CA2064845A1 (en) *	1989-08-17	1991-02-18	Sharad K. Govil	Transdermal nitroglycerin patch with penetration enhancers
WO1991005529A1 (en) *	1989-10-13	1991-05-02	Watson Laboratories, Inc.	Drug delivery systems and matrix therefor
AR246186A1 (en) *	1989-11-17	1994-07-29	Beta Pharm Co	Procedure for manufacturing a device for administering stradiol through the skin.

1992
- 1992-03-25 DE DE4210165A patent/DE4210165A1/en not_active Withdrawn
- 1992-07-07 AT AT92914236T patent/ATE151985T1/en not_active IP Right Cessation
- 1992-07-07 EP EP92914236A patent/EP0596903B1/en not_active Expired - Lifetime
- 1992-07-07 HU HU9400253A patent/HU217215B/en not_active IP Right Cessation
- 1992-07-07 DK DK92914236.2T patent/DK0596903T3/en active
- 1992-07-07 ES ES92914236T patent/ES2103952T3/en not_active Expired - Lifetime
- 1992-07-07 JP JP5503198A patent/JPH06509346A/en not_active Ceased
- 1992-07-07 AU AU22298/92A patent/AU676826B2/en not_active Ceased
- 1992-07-07 CA CA002114537A patent/CA2114537A1/en not_active Abandoned
- 1992-07-07 WO PCT/EP1992/001515 patent/WO1993002669A1/en active IP Right Grant
- 1992-07-07 DE DE59208408T patent/DE59208408D1/en not_active Expired - Fee Related
- 1992-07-29 PT PT100737A patent/PT100737B/en not_active IP Right Cessation
1994
- 1994-01-28 FI FI940427A patent/FI940427L/en unknown
- 1994-01-28 NO NO940313A patent/NO307736B1/en unknown
1997
- 1997-07-15 GR GR970401748T patent/GR3024097T3/en unknown

Also Published As

Publication number	Publication date
EP0596903B1 (en)	1997-04-23
HU9400253D0 (en)	1994-05-30
FI940427A0 (en)	1994-01-28
JPH06509346A (en)	1994-10-20
ES2103952T3 (en)	1997-10-01
WO1993002669A1 (en)	1993-02-18
GR3024097T3 (en)	1997-10-31
EP0596903A1 (en)	1994-05-18
CA2114537A1 (en)	1993-02-18
DK0596903T3 (en)	1997-11-03
AU676826B2 (en)	1997-03-27
HU217215B (en)	1999-12-28
ATE151985T1 (en)	1997-05-15
NO940313L (en)	1994-01-28
PT100737B (en)	1999-07-30
PT100737A (en)	1993-10-29
DE59208408D1 (en)	1997-05-28
AU2229892A (en)	1993-03-02
HUT66125A (en)	1994-09-28
DE4210165A1 (en)	1993-02-04
NO307736B1 (en)	2000-05-22
NO940313D0 (en)	1994-01-28

Publication	Publication Date	Title
FI940427L (en)	1994-01-28	Therapeutic systems that act through the skin
FI934964L (en)	1993-11-10	THERAPEUTIC SUBJECT
FI923379L (en)	1993-01-26	THERAPEUTIC AMIDER
FI935878L (en)	1993-12-27	PORFYCENFOERENINGAR FOER PHOTODYNAMISK THERAPY
DE59209635D1 (en)	1999-04-01	Cardiac therapy system
DE69308324D1 (en)	1997-04-03	TOMOGRAPHY
DK0616523T3 (en)	1998-09-28	drugs
FI924194L (en)	1993-03-20	NAOLECTRODE SYSTEM
NO933878D0 (en)	1993-10-27	ULTRASONIC TREATMENT SYSTEM
FI924456L (en)	1993-04-05	MEDICINE
FI930047L (en)	1993-01-07	SYSTEM FOER EKOAVLAEGSNING OMFATTANDE EN EKOBILDSAVLAEGSNINGSREFERENSSIGNAL
DK0507513T3 (en)	1997-05-05	Therapeutic device
FI924744L (en)	1993-04-22	THERAPEUTIC PRESENT
DE69214558D1 (en)	1996-11-21	Cancer therapy system
FI930114L (en)	1993-07-26	WARM OR KYLVALS
FI923759L (en)	1992-08-20	THERAPEUTIC BENSAZAPINFOERENINGAR
FI930674A0 (en)	1993-02-16	THERAPEUTIC AEMNEN
DE69219279D1 (en)	1997-05-28	Skin cleanser
FI923486A (en)	1992-07-31	THERAPEUTIC AEMNEN.
MX9203214A (en)	1992-07-01	THERAPEUTIC NUCLEOSIDES.
FI931071A0 (en)	1993-03-10	THERAPEUTIC AEMNEN
ATA142091A (en)	1993-03-15	BANDAGE SYSTEM
FI920701A0 (en)	1992-02-18	ANORDNING FOER THERAPEUTIC TRYCK- BEHANDLING.
FI910753A0 (en)	1991-02-15	THERAPEUTIC NUCLEOCIDER.
FI923528A0 (en)	1992-08-05	THERAPEUTIC AEMNEN.